SPECT Equipment Market Size, Trends and Growth Analysis by 2027

The SPECT (Single Photon Emission Computed Tomography) equipment market is anticipated to grow significantly, reaching an estimated US$ 2,109.05 million by 2028, up from US$ 1,552.02 million in 2021. This growth represents a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028.

The rising prevalence of cardiac diseases, cancer, and neurological disorders is driving the need for advanced diagnostic tools. Despite this demand, several factors hinder market expansion, including prolonged scanning durations, subpar image resolution, high costs, a shortage of trained professionals, and various challenges within the medical device sector.

SPECT is a sophisticated imaging modality that allows for the observation of physiological alterations in organs and tissues. It plays a crucial role in the early detection of medical conditions, monitoring treatment efficacy, and conducting research on human physiology. The standalone SPECT system is a type of nuclear medicine imaging technology that utilizes gamma rays. This system captures gamma-ray emissions from a radioisotope that has been injected into the patient, enabling the creation of diagnostic images and facilitating disease management through high-quality, real-time tomographic imaging.

The SPECT equipment market is categorized based on several criteria, including type, radioisotope, application, end user, and geographical region. In terms of type, the market is divided into hybrid SPECT and standalone SPECT. The hybrid SPECT segment is further classified into SPECT-CT and SPECT-MR.

When considering the radioisotope types, the market includes Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and others. In 2021, the Technetium-99m segment dominated the market share, while the Gallium-66 segment is projected to experience the highest CAGR of 6.1% during the forecast period.

Applications of SPECT equipment are diverse, encompassing areas such as seizures, stroke, stress fractures, infections, tumors, and others. The stroke application segment held the largest market share in 2021, with the tumor segment expected to achieve the highest CAGR of 5.7% from 2021 to 2028.

From the perspective of end users, the SPECT equipment market is segmented into hospitals, imaging centers, and other facilities. The hospitals segment accounted for the largest market share in 2021, while the imaging centers segment is projected to grow at the highest CAGR of 5.1% during the forecast period.

Geographically, the market is divided into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South & Central America (SCAM). In North America, the market is further segmented into the US, Canada, and Mexico. Europe is divided into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The APAC region includes China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The MEA market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Lastly, the SCAM region includes Brazil, Argentina, and the Rest of South and Central America.

In preparing the report on the SPECT equipment market, various primary and secondary sources were consulted, including imaging centers, radiology laboratories, nuclear medicine departments, and hospitals.